WS1-2-4 Phase I Clinical Study of Anti-apoptosis Protein, Survivin-derived Peptide Vaccine Therapy for Patients with Advanced or Recurrent Urothelial Cancer(Urothelial Cell Cancer)

Ichiya Honma; Hiroshi Kitamura; Toshihiko Torigoe; Yoshihiko Hirohashi; Eiji Sato; Atsushi Takahashi; Keisuke Taguchi; Naoya Masumori; Naoki Itoh; Noriyuki Sato; Taiji Tsukamoto

doi:10.5980/jpnjurol.99.146_2

本間一也, Hiroshi Kitamura, Toshihiko Torigoe, Yoshihiko Hirohashi, Eiji Sato, Atsushi Takahashi, Keisuke Taguchi, Naoya Masumori, Naoki Itoh, Noriyuki Sato, Taiji Tsukamoto

著者情報

本間一也
Department of Urology, Sapporo Medical University, School of Medicine
Hiroshi Kitamura
Department of Urology, Sapporo Medical University, School of Medicine:1st Department of Pathology, Sapporo Medical University, School of Medicine
Toshihiko Torigoe
1st Department of Pathology, Sapporo Medical University, School of Medicine
Yoshihiko Hirohashi
1st Department of Pathology, Sapporo Medical University, School of Medicine
Eiji Sato
Department of Urology, Sapporo Medical University, School of Medicine:1st Department of Pathology, Sapporo Medical University, School of Medicine
Atsushi Takahashi
Department of Urology, Hakodate Goryokaku Hospital
Keisuke Taguchi
Department of Urology, Oji General Hospital
Naoya Masumori
Department of Urology, Sapporo Medical University, School of Medicine
Naoki Itoh
Department of Urology, Sapporo Medical University, School of Medicine
Noriyuki Sato
1st Department of Pathology, Sapporo Medical University, School of Medicine
Taiji Tsukamoto
Department of Urology, Sapporo Medical University, School of Medicine

ジャーナルフリー

2008 年 99 巻 2 号 p. 146-

DOI https://doi.org/10.5980/jpnjurol.99.146_2

詳細

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）